Cargando…
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
The detection of circulating tumor DNA (ctDNA) in liquid biopsy samples as an oncological marker is being used in clinical trials at every step of clinical management. As ctDNA-based liquid biopsy kits are developed and used in clinics, companies work towards increased convenience, accuracy, and cos...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487653/ https://www.ncbi.nlm.nih.gov/pubmed/37686024 http://dx.doi.org/10.3390/ijms241713219 |